Confirm delete?

Bertin Bioreagent
logo
All categories
Contact Us
You are here :

Article: Tnf-Α-Targeted Therapies In Alzheimer’S Disease

Article: TNF-α-Targeted Therapies in Alzheimer’s Disease

Date : Since 04/04/2024

Place : Paris, France

Bioreagents

This monthly focus highlights the use of Cayman's products for the detection of Alzheimer's disease.

Alzheimer's disease is a neurodegenerative disorder that primarily affects memory, but also thought and behavior.

It is characterized by the formation of amyloid-β (Aβ) plaques and neurofibrillary tangles (NFTs), composed of hyperphosphorylated tau proteins.

 

NEW Article

Discover this new article using Cayman products, distributed by Bertin Bioreagent.

 

Read the article

 

 

 

 

Cayman products and degenerative diseases

	Do you know the favourite products of our customers?Necroptosis research tools, TNFR1 antagonists, Aβ Peptides, ...:

 

Aβ Peptides

Tau Antibodies

Small Molecule Inhibitors of TNF-α/NF-κB Signaling

TNFR1 Antagonists

ADAM17 Inhibitors

Necroptosis Research Tools

RIPK Inhibitors

Top